Medical Research
(H03)
990 on File
PHARMACOGENOMICS RESEARCH NETWORK INC
Financial strength (30%)
73/100
Reliability (20%)
45/100
Effectiveness (25%)
51/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$195K
Total Revenue
$179K
Total Expenses
$197K
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
100.0%
Fundraising Efficiency
N/A
Operating Reserve
13.26x
Liability-to-Asset
10.3%
Revenue Diversification
45.3%
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
100.0% | 84.5% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
13.3 mo | 13.4 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
10.3% | 0.4% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
45.3% | 93.3% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
25.3% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
29.6% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
8.4% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $195K | $179K | $197K | 100.0% | — |
| 2023 | $155K | $138K | $181K | 100.0% | — |
| 2022 | $134K | $103K | $173K | 100.0% | — |
| 2021 | $102K | $27K | $142K | 100.0% | — |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.